...250 patients in a double-blind, placebo-controlled, dose-ranging, European Phase II trial evaluating subcutaneous Purethal Mites. HAL Allergy B.V....
...250 patients in a double-blind, placebo-controlled, dose-ranging, European Phase II trial evaluating subcutaneous Purethal Mites. HAL Allergy B.V....